Dr. Howard Berman is currently the Founder and Executive Chairman of Coya Therapeutics, Inc., a clinical-stage biotechnology company focused on developing disease-modifying therapies for neurodegenerative conditions. With over 20 years of experience at the intersection of science and business, Dr. Berman has held key roles in various pharmaceutical companies, including Novartis, Eli Lilly, and AbbVie. They are a recipient of multiple accolades including the 2024 PharmaVoice 100 award and have an academic background that includes a Bachelor's degree from the University of Michigan and a PhD from Weill Cornell Medical School. Dr. Berman's entrepreneurial spirit also led them to found imaware™, a digital health platform that was successfully acquired in 2024.
This person is not in the org chart
This person is not in any teams
This person is not in any offices